Pub Date : 2022-12-01DOI: 10.4103/0973-3698.364667
M. Bukhari
{"title":"How to get Published?","authors":"M. Bukhari","doi":"10.4103/0973-3698.364667","DOIUrl":"https://doi.org/10.4103/0973-3698.364667","url":null,"abstract":"","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"279 - 280"},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49160382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01DOI: 10.4103/0973-3698.364673
Tony Jacob, P. Sahni
A key step in publishing one's manuscript is selecting the journal. If not done right, your work could lose its relevance. There are numerous factors that you may consider in choosing an appropriate journal for your manuscript and these have been listed out in this article. These include journal metrics, reputation, audience, the range and type of articles that the journal covers, turnaround time, its circulation and reach, and the business model of the journal. We, in this article, have covered certain important metrics of a journal like an impact factor, citation index, rejection rate, and the Eigen factor. We have also described the business models that govern scientific publication today – both the traditional and the open-access model – in adequate detail, along with their key advantages and disadvantages. We hope that this article would help you make the key decision of finding the right journal for your manuscript.
{"title":"Publication models and how to choose the right journal","authors":"Tony Jacob, P. Sahni","doi":"10.4103/0973-3698.364673","DOIUrl":"https://doi.org/10.4103/0973-3698.364673","url":null,"abstract":"A key step in publishing one's manuscript is selecting the journal. If not done right, your work could lose its relevance. There are numerous factors that you may consider in choosing an appropriate journal for your manuscript and these have been listed out in this article. These include journal metrics, reputation, audience, the range and type of articles that the journal covers, turnaround time, its circulation and reach, and the business model of the journal. We, in this article, have covered certain important metrics of a journal like an impact factor, citation index, rejection rate, and the Eigen factor. We have also described the business models that govern scientific publication today – both the traditional and the open-access model – in adequate detail, along with their key advantages and disadvantages. We hope that this article would help you make the key decision of finding the right journal for your manuscript.","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"314 - 318"},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41777986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Reuben Kumar, Sandra Manuel, D. Elizabeth, V. Shobha
Background: Vaccine against COVID-19 is an effective preventive measure; however, systemic lupus erythematosus (SLE) patients were excluded from the vaccine trials, which leads to questions regarding vaccine safety and efficacy, giving rise to vaccine hesitancy. We aim to study the prevalence of vaccine hesitancy among SLE patients and study the factors affecting it. Methods: The study is a cross-sectional telephone-based survey done on SLE patients. The questionnaire included a series of 15 questions pertaining to their baseline characteristics, COVID-19 infection and vaccination details, and their perceptions regarding the COVID-19 vaccine. Nonvaccinated individuals were defined as “willing” and “hesitant” based on their intent to get vaccinated. Results: Among 418 (93% women) participants, about 8% had contracted COVID-19 infection in the past. Nearly half had been vaccinated against COVID-19, and 83% had experienced one or more side effects which were largely mild. Out of the 215 nonvaccinated participants, 84% were “willing” and 16% were “hesitant.” Among the reasons for hesitancy, hasty vaccine production, fear of SLE flares, general vaccine refusal and limited transport facilities were significant. On the whole, 65.1% had a positive attitude toward the vaccine. Conclusion: Despite a low-hesitancy rate, the number of SLE patients with a negative attitude toward the COVID-19 vaccine is reasonably high, with more than half of the patients yet to be vaccinated. This highlights that the mistrust and negative perceptions of the vaccine still persists. The role of health-care providers in vaccine acceptance in SLE patients is crucial.
{"title":"COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs","authors":"Reuben Kumar, Sandra Manuel, D. Elizabeth, V. Shobha","doi":"10.4103/injr.injr_22_22","DOIUrl":"https://doi.org/10.4103/injr.injr_22_22","url":null,"abstract":"Background: Vaccine against COVID-19 is an effective preventive measure; however, systemic lupus erythematosus (SLE) patients were excluded from the vaccine trials, which leads to questions regarding vaccine safety and efficacy, giving rise to vaccine hesitancy. We aim to study the prevalence of vaccine hesitancy among SLE patients and study the factors affecting it. Methods: The study is a cross-sectional telephone-based survey done on SLE patients. The questionnaire included a series of 15 questions pertaining to their baseline characteristics, COVID-19 infection and vaccination details, and their perceptions regarding the COVID-19 vaccine. Nonvaccinated individuals were defined as “willing” and “hesitant” based on their intent to get vaccinated. Results: Among 418 (93% women) participants, about 8% had contracted COVID-19 infection in the past. Nearly half had been vaccinated against COVID-19, and 83% had experienced one or more side effects which were largely mild. Out of the 215 nonvaccinated participants, 84% were “willing” and 16% were “hesitant.” Among the reasons for hesitancy, hasty vaccine production, fear of SLE flares, general vaccine refusal and limited transport facilities were significant. On the whole, 65.1% had a positive attitude toward the vaccine. Conclusion: Despite a low-hesitancy rate, the number of SLE patients with a negative attitude toward the COVID-19 vaccine is reasonably high, with more than half of the patients yet to be vaccinated. This highlights that the mistrust and negative perceptions of the vaccine still persists. The role of health-care providers in vaccine acceptance in SLE patients is crucial.","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"406 - 413"},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45344725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01DOI: 10.4103/injr.injr_146_22
J. Samanta, Debashish Mishra
With the digitalization of the services across various sectors in an Indian setting, health care is also influenced by the same. It was evidenced during the COVID-19 pandemic that Indian patients were orienting themselves toward more teleconsultations and digital and smartphone-based health care. This not only saves time and money but also reduces the chances of hospital-acquired cross infections. This is more important for patients with rheumatic diseases who try to avoid frequent hospital visits despite the need for regular health-care consultations due to the aforementioned reasons. Apart from the telemedicine and smartphone apps, health care is expanding to robotics and artificial intelligence-based machine learning. Healthcare digitalization will lead to the expansion of precision based medicine. When more robust genomics, proteomics, metabolomics, and transcriptomics data become available for Indian patients with rheumatic diseases, management then would be more personalized than blanket therapy. However, such futuristic advancements face challenges of their own which are neither time nor knowledge bound. We are currently just at the tip of this massive iceberg. We describe various aspects of the future of digital health and precision medicine in rheumatology in an Indian setting.
{"title":"Future of digital health and precision medicine in rheumatology practice in India","authors":"J. Samanta, Debashish Mishra","doi":"10.4103/injr.injr_146_22","DOIUrl":"https://doi.org/10.4103/injr.injr_146_22","url":null,"abstract":"With the digitalization of the services across various sectors in an Indian setting, health care is also influenced by the same. It was evidenced during the COVID-19 pandemic that Indian patients were orienting themselves toward more teleconsultations and digital and smartphone-based health care. This not only saves time and money but also reduces the chances of hospital-acquired cross infections. This is more important for patients with rheumatic diseases who try to avoid frequent hospital visits despite the need for regular health-care consultations due to the aforementioned reasons. Apart from the telemedicine and smartphone apps, health care is expanding to robotics and artificial intelligence-based machine learning. Healthcare digitalization will lead to the expansion of precision based medicine. When more robust genomics, proteomics, metabolomics, and transcriptomics data become available for Indian patients with rheumatic diseases, management then would be more personalized than blanket therapy. However, such futuristic advancements face challenges of their own which are neither time nor knowledge bound. We are currently just at the tip of this massive iceberg. We describe various aspects of the future of digital health and precision medicine in rheumatology in an Indian setting.","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"426 - 430"},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47566531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01DOI: 10.4103/injr.injr_150_22
Natasha Ung, R. Grainger
{"title":"Digital technologies in rheumatology: new tools, new skills, and new care","authors":"Natasha Ung, R. Grainger","doi":"10.4103/injr.injr_150_22","DOIUrl":"https://doi.org/10.4103/injr.injr_150_22","url":null,"abstract":"","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"369 - 370"},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48335835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01DOI: 10.4103/INJR.INJR_292_20
I. Benlidayı
The coronavirus disease-19 pandemic has caused a considerable deterioration in medical practices. This resulted in a rapid shift to telemedicine/telehealth as an alternative to conventional interventions and in-person visits. Telerheumatology practices have been increasing worldwide. Virtual consulting for remote physiotherapy advice in rheumatic diseases is also essential. The present topical review aimed to provide an insight to telehealth for musculoskeletal physiotherapy among patients with rheumatic diseases. Patient assessment, goal setting, teleeducation, and providing individual-based, goal-directed exercises are components of telerehabilitation. Telephone/video calls can be used to further progress the exercise program and to evaluate patient adherence. Future studies on the role of virtual consulting for physiotherapy advice in rheumatic diseases would be of value.
{"title":"Virtual consulting for remote physiotherapy advice in chronic rheumatic diseases during the COVID-19 pandemic","authors":"I. Benlidayı","doi":"10.4103/INJR.INJR_292_20","DOIUrl":"https://doi.org/10.4103/INJR.INJR_292_20","url":null,"abstract":"The coronavirus disease-19 pandemic has caused a considerable deterioration in medical practices. This resulted in a rapid shift to telemedicine/telehealth as an alternative to conventional interventions and in-person visits. Telerheumatology practices have been increasing worldwide. Virtual consulting for remote physiotherapy advice in rheumatic diseases is also essential. The present topical review aimed to provide an insight to telehealth for musculoskeletal physiotherapy among patients with rheumatic diseases. Patient assessment, goal setting, teleeducation, and providing individual-based, goal-directed exercises are components of telerehabilitation. Telephone/video calls can be used to further progress the exercise program and to evaluate patient adherence. Future studies on the role of virtual consulting for physiotherapy advice in rheumatic diseases would be of value.","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"414 - 417"},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49071808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01DOI: 10.4103/injr.injr_142_21
Amy MacBrayne, W. Marsh, F. Humby
Rheumatoid arthritis (RA), the archetypal inflammatory arthritis, remains a complex and challenging disease to manage in spite of the abundance of new therapies in the last 20 years. The unpredictable relapsing/remitting nature of RA is at odds with the current prevailing system of scheduled follow-ups, leaving patients with RA to manage pain, flares, and medications between appointments, which may be of little value if occurring during a period of disease control. The rapid progress in the field of mobile health (mHealth) in the last 10 years has led to a proliferation of smartphone applications (apps) targeted at people with RA. Harnessing the power of smartphones to deliver remote monitoring for patients with RA has gone from an exciting possibility to an urgent necessity due to the COVID-19 pandemic. Apps developed solely by commercial providers have been found to be of limited utility in disease monitoring. However, multiple global institutions have developed mHealth technology to support remote monitoring of RA patients, utilizing asynchronous technology for patients to submit indicators of their disease activity, ranging from validated electronic patient-reported outcome measures, to innovative monitoring utilizing smartphone biosensors. This review discusses the current published evidence for mobile applications designed to facilitate remote monitoring of RA, the common barriers faced in implementing mhealth monitoring and strategies to overcome these, and potential areas for future research.
{"title":"Review: Remote disease monitoring in rheumatoid arthritis","authors":"Amy MacBrayne, W. Marsh, F. Humby","doi":"10.4103/injr.injr_142_21","DOIUrl":"https://doi.org/10.4103/injr.injr_142_21","url":null,"abstract":"Rheumatoid arthritis (RA), the archetypal inflammatory arthritis, remains a complex and challenging disease to manage in spite of the abundance of new therapies in the last 20 years. The unpredictable relapsing/remitting nature of RA is at odds with the current prevailing system of scheduled follow-ups, leaving patients with RA to manage pain, flares, and medications between appointments, which may be of little value if occurring during a period of disease control. The rapid progress in the field of mobile health (mHealth) in the last 10 years has led to a proliferation of smartphone applications (apps) targeted at people with RA. Harnessing the power of smartphones to deliver remote monitoring for patients with RA has gone from an exciting possibility to an urgent necessity due to the COVID-19 pandemic. Apps developed solely by commercial providers have been found to be of limited utility in disease monitoring. However, multiple global institutions have developed mHealth technology to support remote monitoring of RA patients, utilizing asynchronous technology for patients to submit indicators of their disease activity, ranging from validated electronic patient-reported outcome measures, to innovative monitoring utilizing smartphone biosensors. This review discusses the current published evidence for mobile applications designed to facilitate remote monitoring of RA, the common barriers faced in implementing mhealth monitoring and strategies to overcome these, and potential areas for future research.","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"384 - 393"},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44105187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01DOI: 10.4103/injr.injr_127_21
Suchitra Kataria, V. Ravindran
India as a country of contrast and diversity has witnessed digital evolution in different waves and stages. The technology is already an integral part of lives of millions in India; however, its application in the health management remains limited unlike developed economies. COVID-19 pandemic has plunged the country into universal, regional, or local lockdowns repeatedly since the last year. An unexpected and unforeseen impact of this has been the usage of technology for doctor–patient interactions through telemedicine. Hitherto limited to certain pockets, virtual interactions with doctors, ordering laboratory investigations through an application or procuring medicines through internet, are now part of mainstream patient behavior. This is a crucial change in the mindset but requires a lot more to be done at various levels to tap its full potential with rheumatologists being at the forefront and leading the change in their specialty. The pool of rheumatologists is very small and mostly concentrated in few urban areas, leading to diagnostic delay, suboptimal treatment, and poor outcomes. Technology could, therefore, become a catalyst for change and harbinger for greater clinician access. There are plenty of discussions about the impact and potential of deep learning, artificial intelligence, remote monitoring with wearables, etc., but plenty of them may not be relevant to Indian patients in the current scenario. Hence, the context, relevance, and applicability are the key for rheumatologists when making a judgment.
{"title":"Digital health and rheumatology: The Indian context","authors":"Suchitra Kataria, V. Ravindran","doi":"10.4103/injr.injr_127_21","DOIUrl":"https://doi.org/10.4103/injr.injr_127_21","url":null,"abstract":"India as a country of contrast and diversity has witnessed digital evolution in different waves and stages. The technology is already an integral part of lives of millions in India; however, its application in the health management remains limited unlike developed economies. COVID-19 pandemic has plunged the country into universal, regional, or local lockdowns repeatedly since the last year. An unexpected and unforeseen impact of this has been the usage of technology for doctor–patient interactions through telemedicine. Hitherto limited to certain pockets, virtual interactions with doctors, ordering laboratory investigations through an application or procuring medicines through internet, are now part of mainstream patient behavior. This is a crucial change in the mindset but requires a lot more to be done at various levels to tap its full potential with rheumatologists being at the forefront and leading the change in their specialty. The pool of rheumatologists is very small and mostly concentrated in few urban areas, leading to diagnostic delay, suboptimal treatment, and poor outcomes. Technology could, therefore, become a catalyst for change and harbinger for greater clinician access. There are plenty of discussions about the impact and potential of deep learning, artificial intelligence, remote monitoring with wearables, etc., but plenty of them may not be relevant to Indian patients in the current scenario. Hence, the context, relevance, and applicability are the key for rheumatologists when making a judgment.","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"377 - 383"},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41390003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01DOI: 10.4103/0973-3698.364681
N. Sandhu, Rhea Wason, A. Goel
The scientific peer review process involves scrutinizing the work of researchers by a panel of scientific experts who are selected by the journal to which they have submitted a manuscript. It ensures that only the best ideas and the highest quality of research are circulated through the publications in the scientific journals. The concept of peer review preceded the development of the scientific journal, has co-evolved with the scientific method, and has now become irreplaceably integrated with it. The traditional method of peer review involved multiple submissions and revisions and was criticized for being time-consuming and biased with the reports of professional misconduct even among the renowned journals. Several guidelines now ensure a more ethical, consistent and rigorous review process. Novel methods of review such as the use of registered reports and the dynamic review methods are also being explored by publishers to deal with these issues. Although the role of peer review as a gatekeeper for high-quality research has been well established, its value in future research is rapidly evolving. Newer methods and adherence to guidelines will go a long way in improving this imperfect pillar of science.
{"title":"Scientific peer review in the modern era: A comprehensive guide","authors":"N. Sandhu, Rhea Wason, A. Goel","doi":"10.4103/0973-3698.364681","DOIUrl":"https://doi.org/10.4103/0973-3698.364681","url":null,"abstract":"The scientific peer review process involves scrutinizing the work of researchers by a panel of scientific experts who are selected by the journal to which they have submitted a manuscript. It ensures that only the best ideas and the highest quality of research are circulated through the publications in the scientific journals. The concept of peer review preceded the development of the scientific journal, has co-evolved with the scientific method, and has now become irreplaceably integrated with it. The traditional method of peer review involved multiple submissions and revisions and was criticized for being time-consuming and biased with the reports of professional misconduct even among the renowned journals. Several guidelines now ensure a more ethical, consistent and rigorous review process. Novel methods of review such as the use of registered reports and the dynamic review methods are also being explored by publishers to deal with these issues. Although the role of peer review as a gatekeeper for high-quality research has been well established, its value in future research is rapidly evolving. Newer methods and adherence to guidelines will go a long way in improving this imperfect pillar of science.","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"342 - 349"},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44905107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：